Home / Research / Manufacturers / DiaSorin Molecular LLC Medical-device intelligence
DiaSorin Molecular LLC: FDA clearances and recalls Research DiaSorin Molecular LLC in public FDA records: applicant and recalling-firm names, product codes, clearance history, and recall records.
Names and coverage This profile groups matching applicant and recalling-firm names found in covered FDA records. It does not imply a complete corporate family, current ownership, or every product marketed under a brand.
Names observed in the source
Diasorin Molecular, LLC DiaSorin Molecular LLC Capitalization and punctuation variants are normalized. Customer-entered watchlist aliases remain private.
Product codes in this company’s records Record activity in this scope 13 clearance records and 8 recall records in the covered releases, across 1 source company names and 12 product codes. Dated history runs from Mar 14, 2018 to Jun 15, 2026.
Monthly counts through October 2026 Month 510(k) decisions Recall initiations October 2025 1 0 November 2025 0 0 December 2025 1 0 January 2026 0 0 February 2026 0 0 March 2026 0 0 April 2026 0 0 May 2026 0 0 June 2026 1 0 July 2026 0 0 August 2026 0 0 September 2026 0 0 October 2026 0 0
Product codes represented All-history totals use the covered releases; monthly counts stop at the last calendar month covered by both sources. Clearances use decision dates; recalls use initiation dates. 0 records lack the required date and are excluded from monthly counts. These are records, not product launches, market share, incidence rates, or comparative safety. Feed filters below do not change this overview.
Clearances and recall records 21 matching records Device / record Company in FDA record Source Source date LIAISON NES Group A Strep; LIAISON NES Group A Strep Control Swab Kit K260333 · PGXDiasorin Molecular, LLC 510(k) Jun 15, 2026FDA decision date LIAISON NES FLU A/B, RSV & COVID-19 K251978 · QOFDiasorin Molecular, LLC 510(k) Dec 23, 2025FDA decision date Simplexa COVID-19/ Flu A/B & RSV Direct (MOL4450); Simplexa COVID-19/ Flu A/B & RSV Positive Control Pack (MOL4460) K252387 · QOFDiasorin Molecular, LLC 510(k) Oct 30, 2025FDA decision date Simplexa Direct Amplification Disc Kit, Rx Only, IVD
The Simplexa Direct Amplification Disc Kit, REF: MOL1455 is 1 box containing 3 Direct Ampli… Z-2153-2023 · OOIDiaSorin Molecular LLC Recall Jul 18, 2023FDA classification date Simplexa COVID-19 & Flu A/B Direct K220963 · QOFDiasorin Molecular, LLC 510(k) Mar 17, 2023FDA decision date Simplexa COVID-19 Direct, REF: MOL4150; including Reaction Mix, REF: MOL4150; with previous assay definition v2 Z-1209-2023 · QJRDiaSorin Molecular LLC Recall Mar 3, 2023FDA classification date Simplexa Flu A/B & RSV Direct Gen II, REF: MOL2655; including Reaction Mix REF: MOL2656; with previous assay definition v5. Z-1210-2023 · OCCDiaSorin Molecular LLC Recall Mar 3, 2023FDA classification date Simplexa Congenital CMV Direct and Simplexa Congenital CMV Positive Control Pack K202755 · QDZDiasorin Molecular, LLC 510(k) Nov 5, 2022FDA decision date Simplexa COVID-19 Direct K212147 · QQXDiasorin Molecular, LLC 510(k) Sep 13, 2022FDA decision date Simplexa Direct Amplification Disc Kit, Product Kit Code MOL1455 Z-0457-2022 · OOIDiaSorin Molecular LLC Recall Jan 5, 2022FDA record creation date SIMPLEXA COVID-19 Positive Control Pack, REF MOL4160, IVD, Rx Only, UDI: (01) 20816101027051 Z-0162-2022 · QJRDiaSorin Molecular LLC Recall Oct 21, 2021FDA record creation date Simplexa Flu A/B & RSV Direct Gen II, Simplexa Flu A/B & RSV Positive Control Pack K201505 · OCCDiasorin Molecular, LLC 510(k) Aug 22, 2020FDA decision date MOL2150 Simplexa HSV 1&2 Direct
-CSF
-Genital Swab
-Cutaneous / Mucocutaneous Swabs
Product Usage: is intended for use on the LIAISON MDX instrum… Z-2547-2020 · OQODiaSorin Molecular LLC Recall Jul 10, 2020FDA classification date MOL3650 Simplexa VZV Direct - Product Usage: is intended for use on the LIAISON MDX instrument for the qualitative detection of varicella-zoster … Z-2548-2020 · PLODiaSorin Molecular LLC Recall Jul 10, 2020FDA classification date MOL3655 Simplexa VZV Swab Direct - Product Usage: is intended for use on the LIAISON MDX instrument for the qualitative detection of varicella-zo… Z-2549-2020 · PGIDiaSorin Molecular LLC Recall Jul 10, 2020FDA classification date Simplexa VZV Swab Direct, Simplexa VZV Positive Control Pack K192376 · PGIDiasorin Molecular, LLC 510(k) Nov 26, 2019FDA decision date Simplexa VZV Direct, Simplexa VZV Positive Control Pack K190219 · PLODiasorin Molecular, LLC 510(k) May 13, 2019FDA decision date Simplexa Bordetella Direct, Simplexa Bordetella Positive Control Pack K183223 · OZZDiasorin Molecular, LLC 510(k) Dec 19, 2018FDA decision date Simplexa GBS Direct, Simplexa GBS Positive Control Pack K182467 · NJRDiasorin Molecular, LLC 510(k) Nov 7, 2018FDA decision date Simplexa Bordetella Direct, Simplexa Bordetella Positive Control Pack K173498 · OZZDiasorin Molecular, LLC 510(k) Aug 13, 2018FDA decision date Simplexa HSV 1 & 2 Direct, Simplexa HSV 1 & 2 Positive Control Pack K173798 · PGIDiasorin Molecular, LLC 510(k) Mar 14, 2018FDA decision date
Device classifications FDA dataset: Nov 9, 2026
Last successful check: Nov 22, 2026
Source classifications may change.
510(k) clearances FDA dataset: Nov 9, 2026
Last successful check: Nov 22, 2026
FDA publishes this dataset monthly.
Recall records FDA dataset: Nov 19, 2026
Last successful check: Nov 22, 2026
FDA publishes this dataset weekly.
Keep this research moving. Follow ten competitors and ten product codes. Get matching changes in your dashboard and a weekly brief, for $49/month.
Start a 14-day free trial ↗